Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-7-13
pubmed:abstractText
The aryl hydrocarbon receptor (AHR) mediates most, if not all, of the many toxicological effects of the environmental pollutant 2,3,7,8-tetrachlorodibenzo- p-dioxin [(TCDD) or dioxin]. The "classical" pathway of AHR action involves dimerization of the liganded AHR with the aryl hydrocarbon nuclear translocator (ARNT) protein, and the AHR-ARNT dimer specifically associates with the enhancer regions of dioxin-responsive genes, leading to their increased transcription. Sutter and coworkers recently reported that epidermal growth factor (EGF) represses the dioxin-mediated induction of CYP1A1 in cultured normal human keratinocytes by inhibiting the recruitment of the transcriptional coactivator protein p300 to the CYP1A1 gene. EGF also inhibits the dioxin-dependent induction of certain parameters in keratinocytes that are reflective of dioxin-induced chloracne. These findings point to the potential usefulness of EGF for the treatment of chloracne and also describe a novel mechanism for repression of dioxin-induced gene transcription.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-12573486, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-12774124, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-14973392, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-15581594, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-16862222, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-16881967, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-16972788, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-17392787, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-18098033, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-18540824, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-18817753, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-18842620, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-19014911, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-19255421, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-19299563, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-19337517, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-6290078, http://linkedlifedata.com/resource/pubmed/commentcorrection/19592671-9860927
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1543-2548
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
116-8
pubmed:dateRevised
2011-8-1
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Repression of aryl hydrocarbon receptor transcriptional activity by epidermal growth factor.
pubmed:affiliation
Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, and Molecular Toxicology Program, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. ohank@mednet.ucla.edu
pubmed:publicationType
Journal Article